Frost & Sullivan Acclaims CordenPharma for Achieving Excellence in Product Differentiation

Feb 16, 2012
frost.PNG
Marc New, Director of API Sales & Marketing, seen here receiving the Product Differentiation Award on behalf of CordenPharma on December 1, 2011 at the Villa Kennedy is Frankfurt, Germany.

Unique Product Mix and Technical Excellence Distinguish CordenPharma from the Competition

LONDON--(Marketwire - Jan 10, 2012) - Based on its recent analysis of the pharmaceutical contract manufacturing market, Frost & Sullivan recognises CordenPharma with the 2011 Western Europe Frost & Sullivan Award for Product Differentiation Excellence.
"CordenPharma offers unparalleled value to pharmaceutical and biotechnology companies by custom manufacturing of complex pharmaceutical materials and drug products," notes Frost & Sullivan Research Analyst Aiswariya Chidambaram. "Leveraging proprietary technologies and flexible production equipment, the company offers its clients an extensive range of high quality products at cost-effective prices."

Read the full press release

Read the 2011 Western Europe Frost & Sullivan Award Report for Product Differentiation Excellence